A modeling framework for evaluation and comparison of trigger strategies for switching from minipool to individual-donation testing for West Nile virus

Transfusion. 2009 Jun;49(6):1151-9. doi: 10.1111/j.1537-2995.2009.02112.x. Epub 2009 Feb 27.

Abstract

Background: To decrease the likelihood of transmission from donations containing West Nile virus (WNV) levels below minipool nucleic acid test (MP-NAT) detection limits, blood centers switch from MP-NAT to individual-donation testing (ID-NAT) after detection of MP-NAT-positive donations. The effectiveness of strategies to trigger or discontinue ID-NAT screening is largely unknown.

Study design and methods: Twenty-seven strategies to trigger and discontinue ID-NAT screening were evaluated with a statistical model based on known dynamics of WNV infection and historical data on WNV prevalence among blood donations. Breakthroughs were defined as WNV immunoglobulin M antibody-negative, viremic (RNA-positive) donations that could only be identified by ID-NAT, but were screened by MP-NAT. Effectiveness (proportional reduction of breakthroughs relative to MP-NAT screening alone) and efficiency (absolute reduction of breakthroughs relative to the number of tests performed) were estimated by simulating donation years of varying outbreak severities over a range of blood collection frequencies.

Results: Most strategies were effective (>75% reduction in breakthroughs) when daily donations exceeded 560. In larger centers (1008 donations daily), effectiveness of trigger-on strategies based on absolute number of MP-NAT-positive donations improved, but worsened for strategies using rate-based criteria. Effectiveness increased slightly by triggering on one MP-NAT-positive rather than two and increased substantially by increasing the duration from 7 to 14 days that no ID-NAT-positive donations are detected before resuming MP-NAT.

Conclusion: Most trigger strategies become effective when test results from at least 560 donations daily are considered. A 14-day ID-NAT period may improve safety relative to the increase in the number of tests performed.

Publication types

  • Comparative Study

MeSH terms

  • Antibodies, Viral / blood
  • Blood Donors*
  • Humans
  • RNA, Viral / blood
  • West Nile virus / genetics
  • West Nile virus / immunology
  • West Nile virus / isolation & purification*

Substances

  • Antibodies, Viral
  • RNA, Viral